In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...